This is not uncommon and may be related to the body adjusting to a rapid increase in B12 availability, especially in patients who were significantly deficient
No meaningful changes in circulating lipid levels were observed
Its intended for adults with obesity, or those who are overweight with a related condition, even if they dont have diabetes
Retatrutide is an investigational once-weekly injectable triple agonist that simultaneously activates GLP-1, GIP, and glucagon receptors to reduce appetite, increase energy expenditure, and improve metabolic control
We dont just prescribe a medication and send you home we partner with you throughout your weight loss journey, providing the medical supervision, lifestyle coaching, and ongoing support needed to achieve and sustain real results